Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, that it has installed additional Nuclear Magnetic Resonance (NMR) equipment which will double Lifespin’s annual laboratory testing capacity

Lifespin will now be able to scan and create the corresponding ...

Single Pass, Inc. CEO, Bill Colone, the initiation of the clinical evaluation for the Kronos Electrocautery device designed to improve the safety of co-axial biopsy procedures.

The single-use, disposable device uses battery current to heat the probe tip to cauterize the tissue damaged by the ...

NaNotics LLC, a biopharmaceutical company developing NaNots™, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood.

A research collaboration with Mass General Cancer Center, a program of Massachusetts General Hospital (MGH) in Boston, to ...

Fresenius Kabi, a global health care company that specializes in pharmaceuticals, medical technologies, and nutrition products for critical and chronic conditions.

That the United States (U.S.) Food and Drug Administration (FDA) has approved its biosimilar, Stimufend® (pegfilgrastim-fpgk), for ...

Novogene at the forefront of cutting-edge next-generation sequencing (NGS) services, has officially Falcon II, a superpowered robot scientist for autonomously intelligent NGS delivery.

Falcon, the precursor of Falcon II, launched in March 2020, and is the first fully optimized, automated, and ...

QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid®.

single-use containers for patients more than 33 lb (15 kg) with Congenital Sucrase-Isomaltase Deficiency (CSID).

Currently, Sucraid® ...